Abstract
Background
Adult patients with moyamoya disease (MMD) occasionally exhibit cerebral hyperperfusion after arterial bypass surgery, leading to persistent cognitive decline. The present supplementary analysis of a prospective 5-year cohort study aimed to determine whether cerebral hyperperfusion after arterial bypass surgery for adult patients with misery perfusion due to ischemic MMD causes cerebral atrophy, and whether the development of cerebral atrophy is related to persistent cognitive decline.
Methods
In total, 31 patients who underwent arterial bypass surgery also underwent fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI) and neuropsychological testing before surgery and at the end of a 5-year follow-up. The development of cerebral hyperperfusion and hyperperfusion syndrome after surgery was defined based on brain perfusion single-photon emission computed tomography (SPECT) findings and clinical symptoms. Univariate and multivariate logistic regression analyses of factors related to the development of cerebral atrophy on FLAIR MRI or cognitive decline on neuropsychological testing at the end of the 5-year follow-up were performed.
Results
Eleven patients (35%) developed cerebral atrophy in the frontal lobe where the superficial temporal artery was anastomosed. Cerebral hyperperfusion on brain perfusion SPECT (odds ratio [OR], 50.6; p = 0.0008) or cerebral hyperperfusion syndrome (OR, 41.8; p = 0.0026) was independently associated with the development of cerebral atrophy, and cerebral atrophy development was significantly associated with cognitive decline (OR, 47.7; p = 0.0010).
Conclusions
Cerebral hyperperfusion after arterial bypass surgery for adult patients with misery perfusion due to ischemic MMD can cause cerebral atrophy related to persistent cognitive decline.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are not publicly available on ethical grounds. However, inquiries regarding these data can be directed to the corresponding author.
Code availability
Not applicable.
Abbreviations
- MMD:
-
Moyamoya disease
- FLAIR:
-
Fluid-attenuated inversion recovery
- MRI:
-
Magnetic resonance imaging
- SPECT:
-
Single-photon emission computed tomography
- CI:
-
Confidence interval
- CBF:
-
Cerebral blood flow
- MCA:
-
Middle cerebral artery
- PET:
-
Positron emission tomography
- WAIS-R:
-
Wechsler Adult Intelligence Scale-Revised
- IQ:
-
Intelligence quotient
- WMS:
-
Wechsler Memory Scale
- MQ:
-
Memory quotient
- Rey test:
-
Rey–Osterrieth Complex Figure test
- CHS:
-
Cerebral hyperperfusion syndrome
- ACH:
-
Asymptomatic cerebral hyperperfusion
References
Camarda C, Torelli P, Pipia C, Battaglini I, Azzarello D, Rosano R, Ventimiglia GD, Sottile G, Cilluffo G, Camarda R (2018) Association between atrophy of the caudate nuclei, global brain atrophy, cerebral small vessel disease and mild parkinsonian signs in neurologically and cognitively healthy subjects aged 45–84 years: A crosssectional study. Curr Alzheimer Res 15:1013–1026
Fujimura M, Tominaga T (2015) Current status of revascularization surgery for moyamoya disease: special consideration for its ‘internal carotid-external carotid (IC-EC) conversion’ as the physiological reorganization system. Tohoku J Exp Med 236:45–53
Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T (2007) Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67:273–282
Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, Tominaga T (2014) Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74:163–170
Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease): Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99:S238–S240
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Ramasamy DP, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R (2020) Disability improvement is associated with less brain atrophy development in multiple sclerosis. AJNR Am J Neuroradiol 41:1577–1583l
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK (2009) Clinical outcome after 450 revascularization procedures for moyamoya disease. J Neurosurg 111:927–935
Hara S, Kudo T, Hayashi S, Inaji M, Tanaka Y, Maehara T, Ishii K, Nariai T (2020) Improvement in cognitive decline after indirect bypass surgery in adult moyamoya disease: implication of 15O-gas positron emission tomography. Ann Nucl Med 34:467–475
Iihara K, Okawa M, Hishikawa T, Yamada N, Fukushima K, Iida H, Miyamoto S (2010) Slowly progressive neuronal death associated with postischemic hyperperfusion in cortical laminar necrosis after high-flow bypass for a carotid intracavernous aneurysm. J Neurosurg 112:1254–1259
Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK (2008) Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis 25:580–586
Koyama M (1985) Clinical psychology of brain damage. Gakuen Sha, Tokyo
Lai PMR, Patel NJ, Frerichs KU, Patel AB, Aziz-Sultan MA, Ogilvy CS, Du R (2021) Direct vs indirect revascularization in a north American cohort of moyamoya disease. Neurosurgery 89:315–322
Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, Cho KS (2012) Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality. Acta Neurochir (Wien) 154:1179–1187
Lezak MD (1995) Neuropsychological assessment, 3rd edn. Oxford University Press, New York
Mansour A, Rashad S, Niizuma K, Fujimura M, Tominaga T (2020) A novel model of cerebral hyperperfusion with blood-brain barrier breakdown, white matter injury, and cognitive dysfunction. J Neurosurg 133:1460–1472
Miyoshi K, Chida K, Kobayashi M, Kubo Y, Yoshida K, Terasaki K, Ogasawara K (2019) Two-year clinical, cerebral hemodynamic, and cognitive outcomes of adult patients undergoing medication alone for symptomatically ischemic moyamoya disease without cerebral misery perfusion: a prospective cohort study. Neurosurgery 84:1233–1241
Narducci A, Kaku Y, Onken J, Blecharz K, Vajkoczy P (2019) In vivo demonstration of blood-brain barrier impairment in moyamoya disease. Acta Neurochir 161:371–378
Narisawa A, Fujimura M, Tominaga T (2009) Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions. Clin Neurol Neurosurg 111:123–126
Ogasawara K, Komoribayashi N, Kobayashi M, Fukuda T, Inoue T, Yamadate K, Ogawa A (2005) Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report. Neurosurgery 56:E1380
Ohue S, Kumon Y, Kohno K, Watanabe H, Iwata S, Ohnishi T (2008) Postoperative temporary neurological deficits in adults with moyamoya disease. Surg Neurol 69:281–287
Östberg A, Ledig C, Katila A, Maanpää HR, Posti JP, Takala R, Tallus J, Glocker B, Rueckert D, Tenovuo O (2020) Volume change in frontal cholinergic structures after traumatic brain injury and cognitive outcome. Front Neurol 11:832
Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268–272
Pedraza MI, de Lera M, Bos D, Calleja AI, Cortijo E, Gómez-Vicente B, Reyes J, Coco-Martín MB, Calonge T, Agulla J, Martínez-Pías E, Talavera B, Pérez-Fernández S, Schüller M, Galván J, Castaño M, Martínez-Galdámez M, Arenillas JF (2020) Brain atrophy and the risk of futile endovascular reperfusion in acute ischemic stroke. Stroke 51:1514–1521
Roder C, Haas P, Fudali M, Fudali M, Milian M, Ernemann U, Meyer PT, Tatagiba M, Khan N (2020) Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H215O PET. Neurosurg Rev 43:1615–1622
Shimada Y, Kojima D, Yoshida J, Kobayashi M, Yoshida K, Fujiwara S, Ogasawara K (2018) Transient symptomatic downregulation of cortical neurotransmitter receptor function due to cerebral hyperperfusion after arterial bypass surgery for a patient with ischemic moyamoya disease. Neurol Med Chir (Tokyo) 58:481–484
Shimada H, Makizako H, Doi T, Park H, Tsutsumimoto K, Verghese J, Suzuki T (2018) Effects of combined physical and cognitive exercises on cognition and mobility in patients with mild cognitive impairment: a randomized clinical Ttrial. J Am Med Dir Assoc 19:584–591
Shinagawa F, Kobayashi S, Fujita K (1990) Japanese Wechsler Adult Intelligence Scale-Revised. Nihon Bunka Kagakusha, Tokyo
Tashiro R, Fujimura M, Katsuki M, Nishizawa T, Tomata Y, Niizuma K, Tominaga T (2021) Prolonged/delayed cerebral hyperperfusion in adult patients with moyamoya disease with RNF213 gene polymorphism c.14576G>A (rs112735431) after superficial temporal artery-middle cerebral artery anastomosis. J Neurosurg 135:417–424
Teng Z, Dong Y, Zhang D, An J, Lv P (2017) Cerebral small vessel disease and post-stroke cognitive impairment. Int J Neurosci 127:824–830
Uchida S, Kubo Y, Oomori D, Yabuki M, Kitakami K, Fujiwara S, Yoshida K, Kobayashi M, Terasaki K, Ogasawara K (2021) Long-term cognitive changes after revascularization surgery in adult patients with ischemic moyamoya disease. Cerebrovasc Dis Extra 11:145–154
Yanagihara W, Chida K, Kobayashi M, Kubo Y, Yoshida K, Terasaki K, Ogasawara K (2018) Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease. J Neurosurg 131:1716–1724
Yoshida J, Yamashita F, Sasaki M, Yoshioka K, Fujiwara S, Kobayashi M, Yoshida K, Kubo Y, Ogasawara K (2020) Adverse effects of pre-existing cerebral small vessel disease on cognitive improvement after carotid endarterectomy. Int J Stroke 15:657–665
Funding
This work was supported in part by Grants-in-Aids for Scientific Research KAKEN from the Japan Society for the Promotion of Science (21K09108 and 21K09157) and from the National Hospital Organization Kamaishi Hospital KENKYUHI.
Author information
Authors and Affiliations
Contributions
Yasukazu Katakura: conception and design, acquisition of data, analysis and interpretation of data; drafting the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Yoshitaka Kubo: conception and design; revising the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Kazumasa Dobashi: conception and design; revising the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Kazuto Kimura: acquisition of data; revising the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Shunrou Fujiwara: conception and design; revising the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Kohei Chida: conception and design; revising the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Masakazu Kobayashi: conception and design; revising the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Kenji Yoshida: conception and design; revising the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Kazunori Terasaki: acquisition of data; revising the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Kuniaki Ogasawara: conception and design, acquisition of data, analysis and interpretation of data; drafting the article critically for important intellectual content; final approval of the version to be published; and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Ethical approval
All procedures in this study were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was reviewed and approved by our institutional ethics committee. Written, informed consent was obtained from all patients or their next of kin prior to participation in the original study.
Consent to participate
Each patient provided written informed consent prior to participation.
Consent for publication
Each patient provided written informed consent prior to publication.
Competing interests
The author (Kuniaki Ogasawara) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Consigned research funds from Nihon Medi-Physics Co., Ltd.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Vascular Neurosurgery—Ischemia.
Rights and permissions
About this article
Cite this article
Katakura, Y., Kubo, Y., Dobashi, K. et al. Delayed development of cerebral atrophy after cerebral hyperperfusion following arterial bypass for adult patients with ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort. Acta Neurochir 164, 1037–1045 (2022). https://doi.org/10.1007/s00701-022-05141-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-022-05141-w